Cite Filings / TARS / 0001193125-25-053971
Feed Companies Filings Check
Sign in
424B5

Prospectus

Tarsus Pharmaceuticals, Inc. · Filed 2025-03-13 · Acc 0001193125-25-053971

Documents 1

  • 424B5 Prospectus , d859610d424b5.htm

Around this filing

  • 2025-03-18 4 Farrow Jeffrey S acquired 8,019 shares (option exercise)
  • 2025-03-18 4 Chief Human Resources Officer acquired 18,885 shares (option exercise)
  • 2025-03-18 4 General Counsel acquired 19,213 shares (option exercise)
  • 2025-03-13 8-K Material agreement · Other events
  • 2025-03-13 424B5 Prospectus
  • 2025-03-12 424B5 Prospectus
  • 2025-03-11 4 Director acquired 7,000 shares (option exercise)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d859610d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…